tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INCY Stock Latest News

Incyte announces additional FDA approval of Opzelura
The FlyIncyte announces additional FDA approval of Opzelura
3h ago
INCY
Incyte’s Povorcitinib Shows Promise but Faces Competitive Challenges: Hold Rating Maintained
PremiumRatings
Incyte’s Povorcitinib Shows Promise but Faces Competitive Challenges: Hold Rating Maintained
14h ago
INCY
Incyte announces new data from STOP-HS clinical trial program at EADV
PremiumThe Fly
Incyte announces new data from STOP-HS clinical trial program at EADV
2d ago
INCY
Incyte price target raised to $104 from $90 at BofA
PremiumThe Fly
Incyte price target raised to $104 from $90 at BofA
14d ago
INCY
Incyte price target raised to $104 from $90 at BofA
PremiumThe Fly
Incyte price target raised to $104 from $90 at BofA
15d ago
INCY
Early notable gainers among liquid option names on September 2nd
PremiumThe FlyEarly notable gainers among liquid option names on September 2nd
16d ago
PEP
TPL
Incyte appoints Soni Basi chief human resources officer
Premium
The Fly
Incyte appoints Soni Basi chief human resources officer
24d ago
INCY
Incyte price target raised to $73 from $67 at JPMorgan
Premium
The Fly
Incyte price target raised to $73 from $67 at JPMorgan
28d ago
INCY
Cytokinetics names Jim Daly to Board of Directors
PremiumThe Fly
Cytokinetics names Jim Daly to Board of Directors
30d ago
CYTK
INCY
Incyte CFO Christiana Stamoulis to Step Down
PremiumCompany Announcements
Incyte CFO Christiana Stamoulis to Step Down
1M ago
8K
INCY
Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
1M ago
IT
ALC
Actuate, Incyte, University of Pittsburgh collaborate on elraglusib trial
PremiumThe Fly
Actuate, Incyte, University of Pittsburgh collaborate on elraglusib trial
1M ago
ACTU
INCY
Incyte upgraded to Overweight from Equal Weight at Wells Fargo
PremiumThe FlyIncyte upgraded to Overweight from Equal Weight at Wells Fargo
1M ago
INCY
Avis Budget downgraded, Sprouts upgraded: Wall Street’s top analyst calls
Premium
The Fly
Avis Budget downgraded, Sprouts upgraded: Wall Street’s top analyst calls
2M ago
CB
DV
Incyte initiated with an Overweight at Barclays
Premium
The Fly
Incyte initiated with an Overweight at Barclays
2M ago
INCY
Incyte’s Strong Financial Performance and Strategic Initiatives Under New Leadership Drive Buy Rating
PremiumRatings
Incyte’s Strong Financial Performance and Strategic Initiatives Under New Leadership Drive Buy Rating
2M ago
INCY
Incyte price target raised to $79 from $73 at Truist
PremiumThe Fly
Incyte price target raised to $79 from $73 at Truist
2M ago
INCY
Incyte price target raised to $60 from $52 at BMO Capital
PremiumThe Fly
Incyte price target raised to $60 from $52 at BMO Capital
2M ago
INCY
Cautious Outlook on Incyte: Sell Rating Amid Long-Term Growth Concerns and Competitive Pressures
PremiumRatings
Cautious Outlook on Incyte: Sell Rating Amid Long-Term Growth Concerns and Competitive Pressures
2M ago
INCY
Incyte price target raised to $68 from $62 at UBS
PremiumThe FlyIncyte price target raised to $68 from $62 at UBS
2M ago
INCY
Incyte price target raised to $103 from $88 at Citi
Premium
The Fly
Incyte price target raised to $103 from $88 at Citi
2M ago
INCY
Incyte’s Strong Q2 2025 Results and Strategic Advances
Premium
Company Announcements
Incyte’s Strong Q2 2025 Results and Strategic Advances
2M ago
INCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >